SummitIn person

8th CNS Drug Delivery Summit

Name: 8th CNS Drug Delivery Summit
Start: 2026-12-01
End: 2026-12-03
Location: Hyatt Regency Boston Harbor

Hosted by Hanson Wade

1 – 3 December 2026
Add to calendar
Apple / Outlook (.ics)Google Calendar
Welcome to kongre.net
Events Categories News
Hyatt Regency Boston Harbor, Boston, United States of America
Clinical MedicineNeurologyHealth SciencesPharmacy & Pharmaceutical Sciences

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Official website

Programme

Published

33 sessions across 3 days

2 rooms · 28 speakers

Browse programme

Registration

Registration is handled by the organiser

Go to registration See registration fees

Key facts

8th CNS Drug Delivery Summit is a summit held 1 – 3 December 2026 in Hyatt Regency Boston Harbor, Boston, United States of America, organised by Hanson Wade.

Dates:: 1 – 3 December 2026
Format:: In person
Venue:: Hyatt Regency Boston Harbor, Boston, United States of America
Subjects:: Neurology, Pharmacy & Pharmaceutical Sciences
Organiser:: Hanson Wade
Official website:: cns-drug-delivery.com

The 8th CNS Drug Delivery Summit is the industry's definitive forum dedicated to overcoming the challenges of brain delivery for therapeutics. Organized by Hanson Wade and taking place from December 1-3, 2026, in Boston, MA, the event unites over 100 global biopharma leaders across neuroscience, biologics, protein engineering, drug delivery, and translational sciences. The summit stands out by addressing the latest clinical validations of blood-brain barrier (BBB) shuttles, novel receptor targets beyond TfR1, oligonucleotide delivery, and focused ultrasound, providing cross-functional content spanning discovery, platform technology, chemistry, and DMPK.

Who should attend

Senior leaders spanning neuroscience, biologics, protein engineering, drug delivery, DMPK, translational sciences, platform development, chemistry, business development, and investment from pharma, biotech, diagnostics, academia, consortia, and regulatory bodies.